Comparison 2. Bisphosphonates versus control (with lung transplantation).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Vertebral fractures	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
1.1 24 months	1		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Non‐vertebral fractures	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2.1 24 months	1		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Total Fractures	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3.1 24 months	1		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Per cent change in BMD, lumbar spine, DXA	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
4.1 24 months	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Per cent change in BMD, femur, DXA	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
5.1 24 months	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Bone pain	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
6.1 24 months	1		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
7 Withdrawals, due to adverse events	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8 Withdrawals, total	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8.1 24 months	1		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
9 Survival	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
9.1 24 months	1		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]